The New England journal of medicine, 2022-09, Vol.387 (11), p.967-977
- Castellano, Jose M.
- Pocock, Stuart J.
- Bhatt, Deepak L.
- Quesada, Antonio J.
- Owen, Ruth
- Fernandez-Ortiz, Antonio
- Sanchez, Pedro L.
- Marin Ortuño, Francisco
- Vazquez Rodriguez, Jose M.
- Domingo-Fernández, Alexandra
- Lozano, Iñigo
- Roncaglioni, Maria C.
- Baviera, Marta
- Foresta, Andreana
- Ojeda-Fernandez, Luisa
- Colivicchi, Furio
- Di Fusco, Stefania A.
- Doehner, Wolfram
- Meyer, Antje
- Schiele, François
- Ecarnot, Fiona
- Linhart, Aleš
- Lubanda, Jean-Claude
- Barczi, Gyorgy
- Merkely, Bela
- Ponikowski, Piotr
- Kasprzak, Marta
- Fernandez Alvira, Juan M.
- Andres, Vicente
- Bueno, Hector
- Collier, Timothy
- Van de Werf, Frans
- Perel, Pablo
- Rodriguez-Manero, Moises
- Alonso Garcia, Angeles
- Proietti, Marco
- Schoos, Mikkel M.
- Simon, Tabassome
- Fernandez Ferro, Jose
- Lopez, Nicolas
- Beghi, Ettore
- Bejot, Yannick
- Vivas, David
- Cordero, Alberto
- Ibañez, Borja
- Fuster, Valentin
2022
Details
- Autor(en) / Beteiligte
- Castellano, Jose M.
- Pocock, Stuart J.
- Bhatt, Deepak L.
- Quesada, Antonio J.
- Owen, Ruth
- Fernandez-Ortiz, Antonio
- Sanchez, Pedro L.
- Marin Ortuño, Francisco
- Vazquez Rodriguez, Jose M.
- Domingo-Fernández, Alexandra
- Lozano, Iñigo
- Roncaglioni, Maria C.
- Baviera, Marta
- Foresta, Andreana
- Ojeda-Fernandez, Luisa
- Colivicchi, Furio
- Di Fusco, Stefania A.
- Doehner, Wolfram
- Meyer, Antje
- Schiele, François
- Ecarnot, Fiona
- Linhart, Aleš
- Lubanda, Jean-Claude
- Barczi, Gyorgy
- Merkely, Bela
- Ponikowski, Piotr
- Kasprzak, Marta
- Fernandez Alvira, Juan M.
- Andres, Vicente
- Bueno, Hector
- Collier, Timothy
- Van de Werf, Frans
- Perel, Pablo
- Rodriguez-Manero, Moises
- Alonso Garcia, Angeles
- Proietti, Marco
- Schoos, Mikkel M.
- Simon, Tabassome
- Fernandez Ferro, Jose
- Lopez, Nicolas
- Beghi, Ettore
- Bejot, Yannick
- Vivas, David
- Cordero, Alberto
- Ibañez, Borja
- Fuster, Valentin
- Titel
- Polypill Strategy in Secondary Cardiovascular Prevention
- Ist Teil von
- The New England journal of medicine, 2022-09, Vol.387 (11), p.967-977
- Ort / Verlag
- United States: Massachusetts Medical Society
- Erscheinungsjahr
- 2022
- Link zum Volltext
- Quelle
- MEDLINE
- Beschreibungen/Notizen
- Among patients with recent MI, therapy with a polypill containing aspirin, ramipril, and atorvastatin led to a lower incidence of major adverse cardiovascular events at a median of 3 years than usual care.
- Sprache
- Englisch
- Identifikatoren
- ISSN: 0028-4793eISSN: 1533-4406DOI: 10.1056/NEJMoa2208275Titel-ID: cdi_proquest_journals_2714739574
- Format
- –
- Schlagworte
- Angiotensin, Angiotensin-Converting Enzyme Inhibitors - adverse effects, Angiotensin-Converting Enzyme Inhibitors - therapeutic use, Aspirin, Aspirin - adverse effects, Aspirin - therapeutic use, Atorvastatin, Atorvastatin - adverse effects, Atorvastatin - therapeutic use, Blood pressure, Cardiology, Cardiology General, Cardiovascular disease, Cardiovascular diseases, Cardiovascular Diseases - etiology, Cardiovascular Diseases - mortality, Cardiovascular Diseases - prevention & control, Cerebral infarction, Clinical Medicine, Confidence intervals, Coronary Disease, Death, Diabetes, Disease prevention, Drug dosages, Drug therapy, Drug therapy, Combination, Heart attack, Heart attacks, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects, Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use, Ischemia, Ischemic Stroke - prevention & control, Myocardial Infarction, Myocardial Infarction - complications, Myocardial Infarction - prevention & control, Myocardial Infarction - therapy, Outpatient-Based Clinical Medicine, Patient compliance, Patient outcomes, Patients, Platelet Aggregation Inhibitors - adverse effects, Platelet Aggregation Inhibitors - therapeutic use, Polypharmacy, Prevention, Ramipril, Ramipril - adverse effects, Ramipril - therapeutic use, Secondary Prevention - methods, Stroke, Testing